A systematic overview of published antimalarial drug trials.

Systematic database searches identified 435 antimalarial drug treatment trials, involving 82,616 patients, conducted and published between 1966 and December 2002. Of these trials 72% were randomised; 64 (15%) trials involved severe malaria, 47 (11%) studied Plasmodium vivax, 3 Plasmodium malariae or...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Myint, H, Tipmanee, P, Nosten, F, Day, N, Pukrittayakamee, S, Looareesuwan, S, White, N
Aineistotyyppi: Journal article
Kieli:English
Julkaistu: 2004
_version_ 1826265969720295424
author Myint, H
Tipmanee, P
Nosten, F
Day, N
Pukrittayakamee, S
Looareesuwan, S
White, N
author_facet Myint, H
Tipmanee, P
Nosten, F
Day, N
Pukrittayakamee, S
Looareesuwan, S
White, N
author_sort Myint, H
collection OXFORD
description Systematic database searches identified 435 antimalarial drug treatment trials, involving 82,616 patients, conducted and published between 1966 and December 2002. Of these trials 72% were randomised; 64 (15%) trials involved severe malaria, 47 (11%) studied Plasmodium vivax, 3 Plasmodium malariae or Plasmodium ovale, and the remainder (74%) assessed treatment responses in uncomplicated falciparum malaria. Twelve trials (2.7%) specifically evaluated antimalarial treatments in pregnant women. Overall 49% of trials were conducted in Asia (29% from Thailand alone) and 42% in Africa. Half of all the patients studied had been in trials published in the past 7 years. There has been a recent rise in the proportion of trial enrolling children, and a tripling in the average number of patients recruited per trial (from approximately 100 in the 1970s to 300 currently). Chloroquine was given to over half the patients in antimalarial drug trials (n = 53552) compared with artemisinin derivatives (n = 12463), mefloquine-sulphadoxine-pyrimethamine (n = 9153), mefloquine (n = 5546) and sulphadoxine-pyrimethamine (n = 5909). The quality of safety and efficacy data for recently evaluated drugs contrasts with a relative paucity of data for older 'established' compounds.
first_indexed 2024-03-06T20:31:52Z
format Journal article
id oxford-uuid:3152d160-cadc-44a3-9a5d-a8480fa48f65
institution University of Oxford
language English
last_indexed 2024-03-06T20:31:52Z
publishDate 2004
record_format dspace
spelling oxford-uuid:3152d160-cadc-44a3-9a5d-a8480fa48f652022-03-26T13:07:12ZA systematic overview of published antimalarial drug trials.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:3152d160-cadc-44a3-9a5d-a8480fa48f65EnglishSymplectic Elements at Oxford2004Myint, HTipmanee, PNosten, FDay, NPukrittayakamee, SLooareesuwan, SWhite, NSystematic database searches identified 435 antimalarial drug treatment trials, involving 82,616 patients, conducted and published between 1966 and December 2002. Of these trials 72% were randomised; 64 (15%) trials involved severe malaria, 47 (11%) studied Plasmodium vivax, 3 Plasmodium malariae or Plasmodium ovale, and the remainder (74%) assessed treatment responses in uncomplicated falciparum malaria. Twelve trials (2.7%) specifically evaluated antimalarial treatments in pregnant women. Overall 49% of trials were conducted in Asia (29% from Thailand alone) and 42% in Africa. Half of all the patients studied had been in trials published in the past 7 years. There has been a recent rise in the proportion of trial enrolling children, and a tripling in the average number of patients recruited per trial (from approximately 100 in the 1970s to 300 currently). Chloroquine was given to over half the patients in antimalarial drug trials (n = 53552) compared with artemisinin derivatives (n = 12463), mefloquine-sulphadoxine-pyrimethamine (n = 9153), mefloquine (n = 5546) and sulphadoxine-pyrimethamine (n = 5909). The quality of safety and efficacy data for recently evaluated drugs contrasts with a relative paucity of data for older 'established' compounds.
spellingShingle Myint, H
Tipmanee, P
Nosten, F
Day, N
Pukrittayakamee, S
Looareesuwan, S
White, N
A systematic overview of published antimalarial drug trials.
title A systematic overview of published antimalarial drug trials.
title_full A systematic overview of published antimalarial drug trials.
title_fullStr A systematic overview of published antimalarial drug trials.
title_full_unstemmed A systematic overview of published antimalarial drug trials.
title_short A systematic overview of published antimalarial drug trials.
title_sort systematic overview of published antimalarial drug trials
work_keys_str_mv AT myinth asystematicoverviewofpublishedantimalarialdrugtrials
AT tipmaneep asystematicoverviewofpublishedantimalarialdrugtrials
AT nostenf asystematicoverviewofpublishedantimalarialdrugtrials
AT dayn asystematicoverviewofpublishedantimalarialdrugtrials
AT pukrittayakamees asystematicoverviewofpublishedantimalarialdrugtrials
AT looareesuwans asystematicoverviewofpublishedantimalarialdrugtrials
AT whiten asystematicoverviewofpublishedantimalarialdrugtrials
AT myinth systematicoverviewofpublishedantimalarialdrugtrials
AT tipmaneep systematicoverviewofpublishedantimalarialdrugtrials
AT nostenf systematicoverviewofpublishedantimalarialdrugtrials
AT dayn systematicoverviewofpublishedantimalarialdrugtrials
AT pukrittayakamees systematicoverviewofpublishedantimalarialdrugtrials
AT looareesuwans systematicoverviewofpublishedantimalarialdrugtrials
AT whiten systematicoverviewofpublishedantimalarialdrugtrials